Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Hepatitis B - Global Clinical Trials Review, 2023
... B Clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis B. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the ... Read More
-
Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) - Global Clinical Trials Review, 2023
... an overview of Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Clinical trials scenario. This report provides top line data relating to the clinical trials on Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma). Report includes an overview of trial numbers and their ... Read More
-
Gallbladder Cancer - Global Clinical Trials Review, 2023
... Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Gallbladder Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the ... Read More
-
Hepatocellular Carcinoma - Global Clinical Trials Review, 2023
... Carcinoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatocellular Carcinoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the ... Read More
-
Chronic Obstructive Pulmonary Disease (COPD) - Global Clinical Trials Review, 2023
... Update provides an overview of Chronic Obstructive Pulmonary Disease (COPD) Clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Obstructive Pulmonary Disease (COPD). Report includes an overview of ... Read More
-
Hypertriglyceridemia - Global Clinical Trials Review, 2023
... scenario. This report provides top line data relating to the clinical trials on Hypertriglyceridemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers ... Read More
-
Oral Mucositis - Global Clinical Trials Review, 2023
... Mucositis Clinical trials scenario. This report provides top line data relating to the clinical trials on Oral Mucositis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the ... Read More
-
Hypothyroidism - Global Clinical Trials Review, 2023
... scenario. This report provides top line data relating to the clinical trials on Hypothyroidism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers ... Read More
-
Idiopathic Inflammatory Myopathy (IIM) - Global Clinical Trials Review, 2023
... an overview of Idiopathic Inflammatory Myopathy (IIM) Clinical trials scenario. This report provides top line data relating to the clinical trials on Idiopathic Inflammatory Myopathy (IIM). Report includes an overview of trial numbers and their ... Read More
-
Osteoporosis - Global Clinical Trials Review, 2023
... scenario. This report provides top line data relating to the clinical trials on Osteoporosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers ... Read More
-
Collagens Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
... Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Collagens pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in ... Read More
-
Acquired Gene or Chromosome Alterations Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
... including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Acquired Gene or Chromosome Alterations pipeline products with comparative analysis of the products at various ... Read More
-
Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
... and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Auto-Immune Diseases pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials ... Read More
-
Insomnia - Opportunity Assessment and Forecast
... the International Classification of Sleep Disorders (Third Edition; ICSD-3) and the Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition; DSM-5), is defined as patient-reported difficulty with sleep initiation or sleep maintenance, despite adequate opportunity ... Read More
-
Global Low-Concentration Atropine Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Gaucher Disease - Opportunity Assessment and Forecast
... regimen for Type 1 GD and Type 3 GD is dominated by ERTs and SRTs (Cerezyme, VPRIV, Elelyso, Cerdelga, Zavesca). There are several unmet needs in the GD landscape, including the lack of effective therapies ... Read More
-
Female Contraceptives in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032
... model for the Female Contraceptives market through 2032. GlobalData estimates 2022 global contraceptives sales to total approximately $7.8 billion across the 7MM covered within this report. The US contributed 74.6% of these sales, generating an ... Read More
-
Bioprocess Validation Market Report 2023-2033
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Rising Demand for Clinical Trials Globally The market for biopharmaceuticals ... Read More
-
Global Pompe Disease Treatment Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... growth of the Pompe Disease Treatment industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Pompe Disease Treatment. The report also introduces players ... Read More
-
Stem Cell Therapy Market by Type (Allogeneic, Autologous), Cell Source (Adipose Tissue, Bone Marrow, Placenta/Umbilical Cord), Therapeutic Application (Musculoskeletal, Wounds, Surgeries, Inflammatory, Autoimmune, Cardiovascular) - Global Forecast to 2028
... is projected to reach USD 615 million by 2028 from USD 286 million in 2023, at a CAGR of 16.5% during the forecast period. Key market players are focusing on developing new stem cell therapies ... Read More
-
Glioblastoma Multiforme (GBM) - Competitive Landscape
... the 16 countries covered in GlobalData’s epidemiology forecast for GBM. Only a handful of innovator treatment options approved for GBM, the current major player in the GBM market is Roche. Out of 803 molecules in ... Read More
-
Neuropathic Pain Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... global neuropathic pain market is on the verge of a substantial growth trajectory, with experts projecting its value to soar from approximately $8.6 billion in 2024 to an estimated $13.5 billion by the end of ... Read More
-
Frost Radar™: Asia-Pacific Contract Research Organizations, 2023
... witnessing the growth of small- to mid-segment pharma/biotech players making significant contributions to drug discovery and development pipelines. Across APAC, local biopharma companies are establishing themselves as key contributors to the drug development pipeline. APAC ... Read More
-
2024 Global Forecast for Ai-Based Clinical Trials (2025-2030 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD ... Read More
-
2024 Global Forecast for Artificial Intelligence (Ai) In Life Sciences (2025-2030 Outlook)-High Tech & Emerging Markets Report
... market for over 50 countries. The product or service category is within the NAICS Computer Systems Design Services industry. The product or service category is within the NAICS Computer Systems Design Services industry. The global ... Read More
Research Assistance
